HIV-1-specific antibody responses during acute and chronic HIV-1 infection - sprookjes - yvandenbroek - TriplyDB

HIV-1-specific antibody responses during acute and chronic HIV-1 infection

HIV-1-specific antibody responses during acute and chronic HIV-1 infection

http://www.wikidata.org/entity/Q35096836

about

HIV-1 superinfection in women broadens and strengthens the neutralizing antibody response Identifying Recent HIV Infections: From Serological Assays to Genomics Immune correlates of vaccine protection against HIV-1 acquisition Developing Combined HIV Vaccine Strategies for a Functional Cure A Chimeric HIV-1 gp120 Fused with Vaccinia Virus 14K (A27) Protein as an HIV Immunogen Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccines 9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response.Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection Humoral immune responses to HIV in the mucosal secretions and sera of HIV-infected women.Evolutionary and structural features of the C2, V3 and C3 envelope regions underlying the differences in HIV-1 and HIV-2 biology and infection.Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activity Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination.Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models.Identification of a new epitope for HIV-neutralizing antibodies in the gp41 membrane proximal external region by an Env-tailored phage display library.B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy.A mechanistic understanding of allosteric immune escape pathways in the HIV-1 envelope glycoprotein.Vital role for CD8+ cells in controlling retroviral infections.Quantification of the epitope diversity of HIV-1-specific binding antibodies by peptide microarrays for global HIV-1 vaccine development An investigation of the breadth of neutralizing antibody response in cats naturally infected with feline immunodeficiency virus Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection Viremic relapse after HIV-1 remission in a perinatally infected child Workshop summary: Novel biomarkers for HIV incidence assay development.Glances in Immunology of HIV and HCV Infection Repeated Vaccination of Cows with HIV Env gp140 during Subsequent Pregnancies Elicits and Sustains an Enduring Strong Env-Binding and Neutralising Antibody Response.Cross-reactive broadly neutralizing antibodies: timing is everything.Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants.Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection.Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170).Strategies for eliciting HIV-1 inhibitory antibodies Role of IL-21 and IL-21 receptor on B cells in HIV infection.Synthetic immunotherapy induces HIV virus specific Th1 cytotoxic response and death of an HIV-1 infected human cell line through classic complement activation.Characterization of plasmablasts in the blood of HIV-infected viremic individuals: evidence for nonspecific immune activation.Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection Antibody Responses After Analytic Treatment Interruption in Human Immunodeficiency Virus-1-Infected Individuals on Early Initiated Antiretroviral Therapy Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16 Domestic cat microsphere immunoassays: detection of antibodies during feline immunodeficiency virus infection The HIV-1 envelope protein gp120 impairs B cell proliferation by inducing TGF-β1 production and FcRL4 expression.Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses.Use of principal components analysis and protein microarray to explore the association of HIV-1-specific IgG responses with disease progression.

P2860

Q21090490-7A51E0BF-B3AE-462C-8822-9FA681571D76 Q26778001-221376D8-43D7-46C1-B053-3CE6338BFB8A Q26778573-6B35948B-E381-431D-BA45-441CDF631467 Q26998898-E95E4EE9-BCA7-436F-B1B9-A472FB72B29F Q27302081-25D9E190-ACC2-44AE-AF67-607C9C84CF97 Q27333734-5C260B5F-9F43-4232-B62B-90684F805664 Q28730532-60B33865-8DD1-4BC3-9C10-6B17AB936FE4 Q33578985-6CE502D4-C723-4815-BF4B-3F5BEE116DD6 Q33620546-BD5982CF-6CCD-44C4-B15B-F2139B6E1B3B Q33624872-127629C3-4704-41BC-93F9-DF399B0CF8E4 Q33809419-7E3D01ED-840D-4D2C-9543-BF6C149A0EFA Q33826951-1D6111DE-7C93-449A-80CC-6B93CCAC9864 Q33977866-5789F5ED-B8D5-4E30-9798-6B4956764A75 Q34455457-6932CB4A-8420-43F1-803D-DF7E8D5484BA Q34488183-6DA057E2-52D7-4A66-9B48-0E51BECEFD0C Q34541705-F0D14678-2E4B-44B8-8501-AC2CF0F93652 Q34733504-CADF7397-C6DE-4A31-B375-806F99ED3D52 Q34742667-85223073-42C1-4330-8C59-3EF828FD8DB9 Q35072515-1E6288D1-3C43-4BB2-8860-665EC100E08D Q35109028-07E91F6F-AEE2-434F-9239-1FD54B99D320 Q35363127-2B3CDC9F-CE0F-4AC3-8FA8-F4C0CD193C34 Q35633017-EC9A92F5-31DC-4798-9ADD-40F6A6179557 Q35979677-BD3F8E83-978B-4188-9F01-0BE8AADD75EC Q36032051-4A1B2B66-CC30-4DDA-83F3-57A1DF095130 Q36051764-72C9A175-4507-45EE-88A0-08FA89EF4EA3 Q36105782-54371070-5858-478D-80CF-8F531128573B Q36246646-3CEC17CE-20BF-4E41-9DED-33886ADD24E6 Q36274030-00609EEE-D2D9-4157-AE57-EF79FFA0F015 Q36421569-EAD4A267-874F-4FF6-8A00-0916BE0D5F38 Q36452155-1669658E-7CA0-4B53-838D-B88B59206B09 Q36670538-88E18A30-CE5C-41D7-9A99-E691CC57B258 Q36766857-7C09A2D2-5416-428D-89BC-8B8371903F71 Q36827309-DCE63F72-F13E-424F-8E76-8DECADA0FD86 Q36886845-78B6619E-78AF-4D43-B741-27EAD18ED9AA Q37091564-AC50346F-E268-4CBE-8DB8-808C60147F0D Q37245752-6AB5614B-F7D6-4C3A-9D08-409380C6AAFF Q37295135-E171EFB0-F7DA-4913-99FB-913F163AE29F Q37409232-A7CA051C-702D-4CB6-AB04-E45F244AE496 Q37426168-52848B85-52F3-4FED-8E6A-ACDFD990DF6B Q37597124-D999EEC3-A2D1-4102-877C-538549AED839

P2860

HIV-1-specific antibody responses during acute and chronic HIV-1 infection

http://www.wikidata.org/entity/Q35096836

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

HIV-1-specific antibody responses during acute and chronic HIV-1 infection

@ast

HIV-1-specific antibody responses during acute and chronic HIV-1 infection

@en

type

label

HIV-1-specific antibody responses during acute and chronic HIV-1 infection

@ast

HIV-1-specific antibody responses during acute and chronic HIV-1 infection

@en

prefLabel

HIV-1-specific antibody responses during acute and chronic HIV-1 infection

@ast

HIV-1-specific antibody responses during acute and chronic HIV-1 infection

@en

P1433

Q35096836-8577345F-46DB-473D-8420-83A1A86F2E8D

P1476

Q35096836-8F32422A-689A-4DE1-872A-A5239626C148

P2093

Q35096836-C0033DE1-6D4F-4C2B-811A-3A771714A944

P2860

Q35096836-0021B8A4-CC2D-4BD0-87E4-9B1698533409

Q35096836-02D2B843-5B31-4838-9F13-1EEA732C26C2

Q35096836-0AA87A15-7644-4132-9BA6-F2240E2CFCE0

Q35096836-0AF44A35-F222-41D8-A02D-3EB35E164AA4

Q35096836-1056E41F-EC86-4D78-AD67-82FC2E20D059

Q35096836-15679343-BB9E-40CF-957C-F09EBB02B546

Q35096836-17F558D5-42FA-4F3C-A6DF-8A75770E61C5

Q35096836-180297AE-6E25-44FA-9883-437B6965246D

Q35096836-276EF2AD-2F35-4DDF-904C-88B82F04A2B8

Q35096836-2A248FFB-FB76-4B30-8E77-FFC69C4233B1

P304

Q35096836-796D0863-F2A5-49A3-8E21-7734C58F8B56

P31

Q35096836-8512B050-B3AB-4AB5-99C5-50D668B40C78

P356

Q35096836-DD3029C0-E6B2-4D0B-A430-1EC5EA019E95

P433

Q35096836-BD2BA7A6-41EA-4A1B-8A00-8DEF9479701C

P478

Q35096836-55CD7AC1-E34E-4487-BDCC-E0235DC1BD79

P50

Q35096836-2B522981-9F2B-4376-8EC4-C78A70108793

P577

Q35096836-8BD6DC76-5EFD-4015-9F6C-2C5772448451

P698

Q35096836-EBDDA762-97DD-46DA-B664-FF2CAE997B85

P921

Q35096836-04F31E39-065C-4481-BA49-67C477772404

P932

Q35096836-9D9FCAE7-47BD-4474-899D-F0A98CE27849

P356

COH.0B013E32832F00C0

P1433

Current Opinion in HIV and AIDS

P1476

HIV-1-specific antibody responses during acute and chronic HIV-1 infection

@en

P2093

Georgia D Tomaras

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections

Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates

Fc receptors and their interactions with immunoglobulins

HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors

Antibody neutralization and escape by HIV-1

IgG Fc receptors

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.

P304

373-379

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/COH.0B013E32832F00C0

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20048700

http://www.w3.org/2001/XMLSchema#string

P921

P932

3133462

http://www.w3.org/2001/XMLSchema#string